A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation

J Virol. 2020 Jun 1;94(12):e00086-20. doi: 10.1128/JVI.00086-20. Print 2020 Jun 1.

Abstract

West Nile virus (WNV), a member of the Flavivirus genus and currently one of the most common arboviruses worldwide, is associated with severe neurological disease in humans. Its high potential to reemerge and rapidly disseminate makes it a bona fide global public health problem. The surface membrane glycoprotein (M) has been associated with Flavivirus-induced pathogenesis. Here, we identified a key amino acid residue at position 36 of the M protein whose mutation impacts WNV secretion and promotes viral attenuation. We also identified a compensatory site at position M-43 whose mutation stabilizes M-36 substitution both in vitro and in vivo Moreover, we found that introduction of the two mutations together confers a full attenuation phenotype and protection against wild-type WNV lethal challenge, eliciting potent neutralizing-antibody production in mice. Our study thus establishes the M protein as a new viral target for rational design of attenuated WNV strains.IMPORTANCE West Nile virus (WNV) is a worldwide (re)emerging mosquito-transmitted Flavivirus causing fatal neurological diseases in humans. However, no human vaccine has been yet approved. One of the most effective live-attenuated vaccines was empirically obtained by serial passaging of wild-type yellow fever Flavivirus However, such an approach is not acceptable nowadays, and the development of a rationally designed vaccine is necessary. Generating molecular infectious clones and mutating specific residues known to be involved in Flavivirus virulence constitute a powerful tool to promote viral attenuation. WNV membrane glycoprotein is thought to carry such essential determinants. Here, we identified two residues of this protein whose substitutions are key to the full and stable attenuation of WNV in vivo, most likely through inhibition of secretion and possible alteration of morphology. Applied to other flaviviruses, this approach should help in designing new vaccines against these viruses, which are an increasing threat to global human health.

Keywords: West Nile virus; attenuation; flavivirus; membrane protein; secretion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Neutralizing / biosynthesis*
  • Antibodies, Viral / biosynthesis*
  • Binding Sites
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Disease Models, Animal
  • Female
  • Gene Expression
  • Membrane Glycoproteins / chemistry
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / immunology
  • Mice
  • Mice, Inbred BALB C
  • Models, Molecular
  • Mutation*
  • Neurons / immunology
  • Neurons / virology
  • Protein Binding
  • Protein Conformation, alpha-Helical
  • Protein Conformation, beta-Strand
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Survival Analysis
  • Vero Cells
  • Viral Proteins
  • West Nile Fever / immunology
  • West Nile Fever / mortality
  • West Nile Fever / pathology
  • West Nile Fever / virology*
  • West Nile virus / genetics*
  • West Nile virus / growth & development
  • West Nile virus / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Membrane Glycoproteins
  • Viral Proteins